SPY314.99-2.06 -0.65%
DIA259.94-3.06 -1.16%
IXIC10,403.23-30.42 -0.29%

Altimmune's Investigational New Drug Application Cleared by the FDA to Conduct a Phase 2 Trial of HepTcell

Benzinga · -